Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 USD | -.--% | +2.00% | -4.97% |
May. 14 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
May. 14 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 2.07M | Sales 2025 * | 54.11M | Capitalization | 217M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -22M | EV / Sales 2024 * | 105 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.01 x |
P/E ratio 2024 * |
-3.56
x | P/E ratio 2025 * |
-10.8
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.13% |
Latest transcript on Ovid Therapeutics Inc.
1 week | +2.00% | ||
1 month | +0.33% | ||
3 months | -10.00% | ||
6 months | +2.86% | ||
Current year | -4.97% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Jeffrey Rona
DFI | Director of Finance/CFO | 55 | 18-12-31 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 59 | 17-06-13 |
Bart Friedman
BRD | Director/Board Member | 79 | 15-11-22 |
Jeremy Levin
CEO | Chief Executive Officer | 70 | 14-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.06 | -.--% | 78,572 |
24-05-30 | 3.06 | +2.00% | 165,122 |
24-05-29 | 3 | -1.64% | 120,082 |
24-05-28 | 3.05 | +1.67% | 107,823 |
24-05-24 | 3 | -0.33% | 113,606 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.97% | 217M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- OVID Stock